Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

Restricted access

Basal cell carcinoma (BCC) of the skin is the most common cancer, with a higher incidence than all other malignancies combined. Although it is rare to metastasize, patients with multiple or frequently recurring BCC can suffer substantial comorbidity and be difficult to manage. Assessment of risk is a key element of management needed to inform treatment selection. The overall management of BCC primarily consists of surgical approaches, with radiation therapy as an alternate or adjuvant option. Many superficial therapies for BCC have been explored and continue to be developed, including topicals, cryosurgery, and photodynamic therapy. Two hedgehog pathway inhibitors were recently approved by the FDA for systemic treatment of advanced and metastatic BCC, and others are in development. The NCCN Guidelines for Basal Cell Skin Cancer, published in full herein, include recommendations for selecting among the various surgical approaches based on patient-, lesion-, and disease-specific factors, as well as guidance on when to use radiation therapy, superficial therapies, and hedgehog pathway inhibitors.

  • 1.

    Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774778.

  • 2.

    Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998–2012. JAMA Dermatol 2015;151:976981.

    • Search Google Scholar
    • Export Citation
  • 3.

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:730.

  • 4.

    Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol 2015 151:10811086.

    • Search Google Scholar
    • Export Citation
  • 5.

    Chen JG, Fleischer AB Jr., Smith ED et al. . Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001;27:10351038.

  • 6.

    Mudigonda T, Pearce DJ, Yentzer BA et al. . The economic impact of nonmelanoma skin cancer: a review. J Natl Compr Canc Netw 2010;8:888896.

  • 7.

    Christenson LJ, Borrowman TA, Vachon CM et al. . Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681690.

    • Search Google Scholar
    • Export Citation
  • 8.

    Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977–1978 and 1998–1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 2003;12:11051108.

    • Search Google Scholar
    • Export Citation
  • 9.

    Brewster DH, Bhatti LA, Inglis JH et al. . Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol 2007;156:12951300.

    • Search Google Scholar
    • Export Citation
  • 10.

    Hayes RC, Leonfellner S, Pilgrim W et al. . Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J Cutan Med Surg 2007;11:4552.

    • Search Google Scholar
    • Export Citation
  • 11.

    Karagas MR, Greenberg ER, Spencer SK et al. . Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999;81:555559.

    • Search Google Scholar
    • Export Citation
  • 12.

    Staples MP, Elwood M, Burton RC et al. . Nonmelanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006;184:610.

    • Search Google Scholar
    • Export Citation
  • 13.

    Demers AA, Nugent Z, Mihalcioiu C et al. . Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 2005;53:320328.

    • Search Google Scholar
    • Export Citation
  • 14.

    Kricker A, English DR, Randell PL et al. . Skin cancer in Geraldton, Western Australia: a survey of incidence and prevalence. Med J Aust 1990;152:399407.

    • Search Google Scholar
    • Export Citation
  • 15.

    Abbas M, Kalia S. Trends in non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma) in Canada: a descriptive analysis of available data. J Cutan Med Surg 2016;20:166175.

    • Search Google Scholar
    • Export Citation
  • 16.

    Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges 2015;13:788797.

    • Search Google Scholar
    • Export Citation
  • 17.

    Bernat Garcia J, Morales Suarez-Varela M, Vilata JJ et al. . Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region. Acta Derm Venereol 2013;93:422427.

    • Search Google Scholar
    • Export Citation
  • 18.

    Sella T, Goren I, Shalev V et al. . Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006–11. Br J Dermatol 2015;172:202207.

  • 19.

    Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 1995;60:489494.

    • Search Google Scholar
    • Export Citation
  • 20.

    Kricker A, Armstrong BK, English DR, Heenan PJ. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995;60:482488.

  • 21.

    Zanetti R, Rosso S, Martinez C et al. . Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multicentre case–case-control study. Br J Cancer 2006;94:743751.

    • Search Google Scholar
    • Export Citation
  • 22.

    Gallagher RP, Hill GB, Bajdik CD et al. . Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131:157163.

    • Search Google Scholar
    • Export Citation
  • 23.

    Ramsay HM, Fryer AA, Hawley CM et al. . Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003;49:397406.

    • Search Google Scholar
    • Export Citation
  • 24.

    Kaskel P, Lange U, Sander S et al. . Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany. J Eur Acad Dermatol Venereol 2015;29:134142.

    • Search Google Scholar
    • Export Citation
  • 25.

    Khalesi M, Whiteman DC, Tran B et al. . A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiol 2013;37:534543.

    • Search Google Scholar
    • Export Citation
  • 26.

    Walther U, Kron M, Sander S et al. . Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170178.

    • Search Google Scholar
    • Export Citation
  • 27.

    Box NF, Duffy DL, Irving RE et al. . Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001;116:224229.

    • Search Google Scholar
    • Export Citation
  • 28.

    Lock-Andersen J, Drzewiecki KT, Wulf HC. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma: a Danish case-control study. Acta Derm Venereol 1999;79:7480.

    • Search Google Scholar
    • Export Citation
  • 29.

    Chinem VP, Miot HA. Prevalence of actinic skin lesions in patients with basal cell carcinoma of the head: a case-control study. Rev Assoc Med Bras 2012;58:188196.

    • Search Google Scholar
    • Export Citation
  • 30.

    Perkins JL, Liu Y, Mitby PA et al. . Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. J Clin Oncol 2005;23:37333741.

    • Search Google Scholar
    • Export Citation
  • 31.

    Karagas MR, Nelson HH, Zens MS et al. . Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology 2007;18:776784.

    • Search Google Scholar
    • Export Citation
  • 32.

    Watt TC, Inskip PD, Stratton K et al. . Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2012;104:12401250.

    • Search Google Scholar
    • Export Citation
  • 33.

    Schwartz JL, Kopecky KJ, Mathes RW et al. . Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat Res 2009;171:155163.

    • Search Google Scholar
    • Export Citation
  • 34.

    Lichter MD, Karagas MR, Mott LA et al. . Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000;136:10071011.

    • Search Google Scholar
    • Export Citation
  • 35.

    Karagas MR, McDonald JA, Greenberg ER et al. . Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996;88:18481853.

    • Search Google Scholar
    • Export Citation
  • 36.

    Kumar S, Mahajan BB, Kaur S et al. . A study of Basal cell carcinoma in South asians for risk factor and clinicopathological characterization: a hospital based study. J Skin Cancer 2014;2014:173582.

    • Search Google Scholar
    • Export Citation
  • 37.

    English DR, Kricker A, Heenan PJ et al. . Incidence of non-melanocytic skin cancer in Geraldton, Western Australia. Int J Cancer 1997;73:629633.

  • 38.

    Zargaran M, Moghimbeigi A, Monsef A et al. . A clinicopathological survey of basal cell carcinoma in an Iranian population. J Dent (Shiraz) 2013;14:170177.

    • Search Google Scholar
    • Export Citation
  • 39.

    Lesiak A, Sobolewska-Sztychny D, Majak P et al. . Relation between sonic hedgehog pathway gene polymorphisms and basal cell carcinoma development in the Polish population. Arch Dermatol Res 2016;308:3947.

    • Search Google Scholar
    • Export Citation
  • 40.

    Reifenberger J, Wolter M, Weber RG et al. . Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998;58:17981803.

    • Search Google Scholar
    • Export Citation
  • 41.

    Xie J, Murone M, Luoh SM et al. . Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 1998;391:9092.

  • 42.

    Gailani MR, Bale SJ, Leffell DJ et al. . Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992;69:111117.

    • Search Google Scholar
    • Export Citation
  • 43.

    Soufir N, Gerard B, Portela M et al. . PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. Br J Cancer 2006;95:548553.

    • Search Google Scholar
    • Export Citation
  • 44.

    Hahn H, Wicking C, Zaphiropoulous PG et al. . Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841851.

    • Search Google Scholar
    • Export Citation
  • 45.

    Chidambaram A, Goldstein AM, Gailani MR et al. . Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients. Cancer Res 1996;56:45994601.

    • Search Google Scholar
    • Export Citation
  • 46.

    Ling G, Ahmadian A, Persson A et al. . PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 2001;20:77707778.

  • 47.

    Pastorino L, Cusano R, Nasti S et al. . Molecular characterization of Italian nevoid basal cell carcinoma syndrome patients. Hum Mutat 2005;25:322323.

    • Search Google Scholar
    • Export Citation
  • 48.

    Wang W, Wang J, Li J et al. . New mutation of the patched homologue 1 gene in a Chinese family with naevoid basal cell carcinoma syndrome. Br J Oral Maxillofac Surg 2009;47:366369.

    • Search Google Scholar
    • Export Citation
  • 49.

    Aszterbaum M, Rothman A, Johnson RL et al. . Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 1998;110:885888.

    • Search Google Scholar
    • Export Citation
  • 50.

    Heitzer E, Lassacher A, Quehenberger F et al. . UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype. J Invest Dermatol 2007;127:28722881.

    • Search Google Scholar
    • Export Citation
  • 51.

    Danaee H, Karagas MR, Kelsey KT et al. . Allelic loss at Drosophila patched gene is highly prevalent in basal and squamous cell carcinomas of the skin. J Invest Dermatol 2006;126:11521158.

    • Search Google Scholar
    • Export Citation
  • 52.

    Reifenberger J, Wolter M, Knobbe CB et al. . Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005;152:4351.

    • Search Google Scholar
    • Export Citation
  • 53.

    Kim MY, Park HJ, Baek SC et al. . Mutations of the p53 and PTCH gene in basal cell carcinomas: UV mutation signature and strand bias. J Dermatol Sci 2002;29:19.

    • Search Google Scholar
    • Export Citation
  • 54.

    Gailani MR, Stahle-Backdahl M, Leffell DJ et al. . The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996;14:7881.

    • Search Google Scholar
    • Export Citation
  • 55.

    Zhang H, Ping XL, Lee PK et al. . Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol 2001;158:381385.

  • 56.

    Daya-Grosjean L, Sarasin A. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients. Mutat Res 2000;450:193199.

    • Search Google Scholar
    • Export Citation
  • 57.

    Teh MT, Blaydon D, Chaplin T et al. . Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 2005;65:85978603.

    • Search Google Scholar
    • Export Citation
  • 58.

    Ziegler A, Leffell DJ, Kunala S et al. . Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 1993;90:42164220.

    • Search Google Scholar
    • Export Citation
  • 59.

    Ghaderi R, Haghighi F. Immunohistochemistry assessment of p53 protein in basal cell carcinoma. Iran J Allergy Asthma Immunol 2005;4:167171.

    • Search Google Scholar
    • Export Citation
  • 60.

    Rosenstein BS, Phelps RG, Weinstock MA et al. . p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochem Photobiol 1999;70:798806.

    • Search Google Scholar
    • Export Citation
  • 61.

    Oluwasanmi JO, Williams AO, Alli AF. Superficial cancer in Nigeria. Br J Cancer 1969;23:714728.

  • 62.

    Yakubu A, Mabogunje OA. Skin cancer in Zaria, Nigeria. Trop Doct 1995;25(Suppl 1):6367.

  • 63.

    Halkud R, Shenoy AM, Naik SM et al. . Xeroderma pigmentosum: clinicopathological review of the multiple oculocutaneous malignancies and complications. Indian J Surg Oncol 2014;5:120124.

    • Search Google Scholar
    • Export Citation
  • 64.

    Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241250.

    • Search Google Scholar
    • Export Citation
  • 65.

    Bradford PT, Goldstein AM, Tamura D et al. . Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 2011;48:168176.

    • Search Google Scholar
    • Export Citation
  • 66.

    Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer: the xeroderma pigmentosum paradigm. Arch Dermatol 1994;130:10181021.

    • Search Google Scholar
    • Export Citation
  • 67.

    Kraemer KH, Lee MM, Scotto J. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis 1984;5:511514.

    • Search Google Scholar
    • Export Citation
  • 68.

    Couve-Privat S, Le Bret M, Traiffort E et al. . Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients. Cancer Res 2004;64:35593565.

    • Search Google Scholar
    • Export Citation
  • 69.

    Couve-Privat S, Bouadjar B, Avril MF et al. . Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002;62:71867189.

    • Search Google Scholar
    • Export Citation
  • 70.

    D'Errico M, Calcagnile A, Canzona F et al. . UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene 2000;19:463467.

    • Search Google Scholar
    • Export Citation
  • 71.

    Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968;218:652656.

  • 72.

    Thielmann HW, Popanda O, Edler L, Jung EG. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany. Cancer Res 1991;51:34563470.

    • Search Google Scholar
    • Export Citation
  • 73.

    Grossman L. Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ Health Perspect 1997;105(Suppl 4):927930.

  • 74.

    Bodak N, Queille S, Avril MF et al. . High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci U S A 1999;96:51175122.

    • Search Google Scholar
    • Export Citation
  • 75.

    Miller KL, Karagas MR, Kraft P et al. . XPA, haplotypes, and risk of basal and squamous cell carcinoma. Carcinogenesis 2006;27:16701675.

  • 76.

    Chen J, Ruczinski I, Jorgensen TJ et al. . Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 2008;100:12151222.

  • 77.

    Maloney ME, Miller SJ. Aggressive vs nonaggressive subtypes (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Science; 1998:609613.

    • Search Google Scholar
    • Export Citation
  • 78.

    Salasche SJ. Features associated with recurrence (squamous cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Science; 1998:494499.

    • Search Google Scholar
    • Export Citation
  • 79.

    Gandhi MR, Panizza B, Kennedy D. Detecting and defining the anatomic extent of large nerve perineural spread of malignancy: comparing “targeted” MRI with the histologic findings following surgery. Head Neck 2011;33:469475.

    • Search Google Scholar
    • Export Citation
  • 80.

    Williams LS, Mancuso AA, Mendenhall WM. Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis. Int J Radiat Oncol Biol Phys 2001;49:10611069.

    • Search Google Scholar
    • Export Citation
  • 81.

    Boeta-Angeles L, Bennett RG. Features associated with recurrence (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Science; 1998:646656.

    • Search Google Scholar
    • Export Citation
  • 82.

    Silverman MK, Kopf AW, Bart RS et al. . Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992;18:471476.

    • Search Google Scholar
    • Export Citation
  • 83.

    Silverman MK, Kopf AW, Grin CM et al. . Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720726.

    • Search Google Scholar
    • Export Citation
  • 84.

    Dubin N, Kopf AW. Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol 1983;119:373377.

  • 85.

    Bogelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007;87:330334.

  • 86.

    Rigel DS, Robins P, Friedman RJ. Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. J Dermatol Surg Oncol 1981;7:807810.

    • Search Google Scholar
    • Export Citation
  • 87.

    von Domarus H, Stevens PJ. Metastatic basal cell carcinoma: report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984;10:10431060.

    • Search Google Scholar
    • Export Citation
  • 88.

    Nguyen-Nielsen M, Wang L, Pedersen L et al. . The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997–2010. Eur J Dermatol 2015;25:463488.

    • Search Google Scholar
    • Export Citation
  • 89.

    Snow SN, Sahl W, Lo JS et al. . Metastatic basal cell carcinoma: report of five cases. Cancer 1994;73:328335.

  • 90.

    Swanson NA. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol 1983;119:761773.

  • 91.

    Swanson NA, Johnson TM. Management of basal and squamous cell carcinoma. In: Cummings C, ed. Otolaryngology Head and Neck Surgery. New York: Mosby Yearbook; 1998:486501.

    • Search Google Scholar
    • Export Citation
  • 92.

    van Iersel CA, van de Velden HV, Kusters CD et al. . Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005;153:10781080.

    • Search Google Scholar
    • Export Citation
  • 93.

    Spiller WF, Spiller RF. Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 1984;11:808814.

  • 94.

    Petrovich Z, Kuisk H, Langholz B et al. . Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg 1987;154:447450.

    • Search Google Scholar
    • Export Citation
  • 95.

    Silverman MK, Kopf AW, Grin CM et al. . Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol 1991;17:713718.

  • 96.

    Connolly AH, Baker DR, Coldiron BM et al. . AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. Dermatol Surg 2012;38:15821603.

    • Search Google Scholar
    • Export Citation
  • 97.

    Dixon AY, Lee SH, McGregor DH. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol 1993;20:137142.

    • Search Google Scholar
    • Export Citation
  • 98.

    Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982;49:533537.

  • 99.

    de Rosa G, Vetrani A, Zeppa P et al. . Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer 1990;65:544549.

    • Search Google Scholar
    • Export Citation
  • 100.

    Sloane JP. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 1977;96:127132.

  • 101.

    Codazzi D, Van Der Velden J, Carminati M et al. . Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas: associated risk factors and preferred surgical management. J Plast Surg Hand Surg 2014;48:3843.

    • Search Google Scholar
    • Export Citation
  • 102.

    Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA follow-up study. J Natl Cancer Inst 1998;90:12781284.

    • Search Google Scholar
    • Export Citation
  • 103.

    Archier E, Devaux S, Castela E et al. . Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012;26(Suppl 3):2231.

    • Search Google Scholar
    • Export Citation
  • 104.

    Krynitz B, Olsson H, Lundh Rozell B et al. . Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study. Br J Dermatol 2016;174:95103.

    • Search Google Scholar
    • Export Citation
  • 105.

    Mackintosh LJ, Geddes CC, Herd RM. Skin tumours in the West of Scotland renal transplant population. Br J Dermatol 2013;168:10471053.

  • 106.

    Karczewski M, Stronka M, Karczewski J, Wiktorowicz K. Skin cancer following kidney transplantation: a single-center experience. Transplant Proc 2011;43:37603761.

    • Search Google Scholar
    • Export Citation
  • 107.

    Bordea C, Wojnarowska F, Millard PR et al. . Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574579.

    • Search Google Scholar
    • Export Citation
  • 108.

    DePry JL, Vyas R, Lazarus HM et al. . Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review. JAMA Dermatol 2015;151:775782.

    • Search Google Scholar
    • Export Citation
  • 109.

    Park GH, Chang SE, Won CH et al. . Incidence of primary skin cancer after organ transplantation: an 18-year single-center experience in Korea. J Am Acad Dermatol 2014;70:465472.

    • Search Google Scholar
    • Export Citation
  • 110.

    Jensen AO, Svaerke C, Farkas D et al. . Skin cancer risk among solid organ recipients: a nationwide cohort study in Denmark. Acta Derm Venereol 2010;90:474479.

    • Search Google Scholar
    • Export Citation
  • 111.

    Hartevelt MM, Bavinck JN, Kootte AM et al. . Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990;49:506509.

    • Search Google Scholar
    • Export Citation
  • 112.

    Harwood CA, Mesher D, McGregor JM et al. . A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant 2013;13:119129.

    • Search Google Scholar
    • Export Citation
  • 113.

    Brewer JD, Colegio OR, Phillips PK et al. . Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009;145:13911396.

  • 114.

    Rashtak S, Dierkhising RA, Kremers WK et al. . Incidence and risk factors for skin cancer following lung transplantation. J Am Acad Dermatol 2015;72:9298.

    • Search Google Scholar
    • Export Citation
  • 115.

    Fortina AB, Piaserico S, Caforio AL et al. . Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004;140:10791085.

    • Search Google Scholar
    • Export Citation
  • 116.

    Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 2003;139:11331137.

    • Search Google Scholar
    • Export Citation
  • 117.

    Harwood CA, Proby CM, McGregor JM et al. . Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006;54:290300.

    • Search Google Scholar
    • Export Citation
  • 118.

    Lott DG, Manz R, Koch C, Lorenz RR. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation 2010;90:683687.

    • Search Google Scholar
    • Export Citation
  • 119.

    Martin H, Strong E, Spiro RH. Radiation-induced skin cancer of the head and neck. Cancer 1970;25:6171.

  • 120.

    Hassanein AM, Proper SA, Depcik-Smith ND, Flowers FP. Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery. Dermatol Surg 2005;31:11011106.

    • Search Google Scholar
    • Export Citation
  • 121.

    Jackson JE, Dickie GJ, Wiltshire KL et al. . Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approach. Head Neck 2009;31:604610.

    • Search Google Scholar
    • Export Citation
  • 122.

    Lin C, Tripcony L, Keller J et al. . Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features. Int J Radiat Oncol Biol Phys 2012;82:334340.

    • Search Google Scholar
    • Export Citation
  • 123.

    Garcia-Serra A, Hinerman RW, Mendenhall WM et al. . Carcinoma of the skin with perineural invasion. Head Neck 2003;25:10271033.

  • 124.

    Lin C, Tripcony L, Keller J et al. . Cutaneous carcinoma of the head and neck with clinical features of perineural infiltration treated with radiotherapy. Clin Oncol (R Coll Radiol) 2013;25:362367.

    • Search Google Scholar
    • Export Citation
  • 125.

    Leibovitch I, Huilgol SC, Selva D et al. . Basal cell carcinoma treated with Mohs surgery in Australia III: perineural invasion. J Am Acad Dermatol 2005;53:458463.

    • Search Google Scholar
    • Export Citation
  • 126.

    Ratner D, Lowe L, Johnson TM, Fader DJ. Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer 2000;88:16051613.

    • Search Google Scholar
    • Export Citation
  • 127.

    Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000;22:123125.

    • Search Google Scholar
    • Export Citation
  • 128.

    Galloway TJ, Morris CG, Mancuso AA et al. . Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion. Cancer 2005;103:12541257.

    • Search Google Scholar
    • Export Citation
  • 129.

    Balamucki CJ, DeJesus R, Galloway TJ et al. . Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol 2015;38:248251.

    • Search Google Scholar
    • Export Citation
  • 130.

    Cernea CR, Ferraz AR, de Castro IV et al. . Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked. ORL J Otorhinolaryngol Relat Spec 2009;71:2126.

    • Search Google Scholar
    • Export Citation
  • 131.

    Leffell DJ, Headington JT, Wong DS, Swanson NA. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991;127:16631667.

  • 132.

    McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: a possible indicator of differing causes. Arch Dermatol 1997;133:593596.

    • Search Google Scholar
    • Export Citation
  • 133.

    Bastiaens MT, Hoefnagel JJ, Bruijn JA et al. . Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998;110:880884.

    • Search Google Scholar
    • Export Citation
  • 134.

    Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:4147.

    • Search Google Scholar
    • Export Citation
  • 135.

    Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol 2006;155:401407.

    • Search Google Scholar
    • Export Citation
  • 136.

    Dinehart SM, Dodge R, Stanley WE et al. . Basal cell carcinoma treated with Mohs surgery: a comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol 1992;18:560566.

    • Search Google Scholar
    • Export Citation
  • 137.

    Milroy CJ, Horlock N, Wilson GD, Sanders R. Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg 2000;53:393396.

  • 138.

    Roudier-Pujol C, Auperin A, Nguyen T et al. . Basal cell carcinoma in young adults: not more aggressive than in older patients. Dermatology 1999;199:119123.

    • Search Google Scholar
    • Export Citation
  • 139.

    Lear JT, Smith AG, Bowers B et al. . Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction. J Invest Dermatol 1997;108:519522.

    • Search Google Scholar
    • Export Citation
  • 140.

    Ramachandran S, Fryer AA, Lovatt T et al. . The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation. Carcinogenesis 2002;23:20512054.

    • Search Google Scholar
    • Export Citation
  • 141.

    Cheretis C, Angelidou E, Dietrich F et al. . Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma. Med Sci Monit 2008;14:MT1319.

    • Search Google Scholar
    • Export Citation
  • 142.

    Karagas MR, Stukel TA, Greenberg ER et al. . Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 1992;267:33053310.

    • Search Google Scholar
    • Export Citation
  • 143.

    Lovatt TJ, Lear JT, Bastrilles J et al. . Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 2005;52:468473.

    • Search Google Scholar
    • Export Citation
  • 144.

    Levi F, Randimbison L, Maspoli M et al. . High incidence of second basal cell skin cancers. Int J Cancer 2006;119:15051507.

  • 145.

    Richmond-Sinclair NM, Pandeya N, Williams GM et al. . Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study. Int J Cancer 2010;127:26222629.

    • Search Google Scholar
    • Export Citation
  • 146.

    Kiiski V, de Vries E, Flohil SC et al. . Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010;146:848855.

  • 147.

    Flohil SC, Koljenovic S, de Haas ER et al. . Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011;165:874881.

    • Search Google Scholar
    • Export Citation
  • 148.

    Verkouteren JA, Smedinga H, Steyerberg EW et al. . Predicting the risk of a second basal cell carcinoma. J Invest Dermatol 2015;135:26492456.

  • 149.

    Milan T, Pukkala E, Verkasalo PK et al. . Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 2000;87:283288.

    • Search Google Scholar
    • Export Citation
  • 150.

    McCusker M, Basset-Seguin N, Dummer R et al. . Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 2014;50:774783.

    • Search Google Scholar
    • Export Citation
  • 151.

    Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989;11:222232.

  • 152.

    Smeets NW, Kuijpers DI, Nelemans P et al. . Mohs' micrographic surgery for treatment of basal cell carcinoma of the face: results of a retrospective study and review of the literature. Br J Dermatol 2004;151:141147.

    • Search Google Scholar
    • Export Citation
  • 153.

    Cigna E, Tarallo M, Maruccia M et al. . Basal cell carcinoma: 10 years of experience. J Skin Cancer 2011;2011:476362.

  • 154.

    Szewczyk MP, Pazdrowski J, Danczak-Pazdrowska A et al. . Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma. Postepy Dermatol Alergol 2014;31:146151.

    • Search Google Scholar
    • Export Citation
  • 155.

    Bartos V, Pokorny D, Zacharova O et al. . Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Pannonica Adriat 2011;20:6775.

    • Search Google Scholar
    • Export Citation
  • 156.

    Sartore L, Lancerotto L, Salmaso M et al. . Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep 2011;26:14231429.

    • Search Google Scholar
    • Export Citation
  • 157.

    Costantino D, Lowe L, Brown DL. Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg 2006;59:424428.

    • Search Google Scholar
    • Export Citation
  • 158.

    Martin RC 2nd, Edwards MJ, Cawte TG et al. . Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer 2000;88:13651369.

  • 159.

    Garcia C, Poletti E, Crowson AN. Basosquamous carcinoma. J Am Acad Dermatol 2009;60:137143.

  • 160.

    Wermker K, Roknic N, Goessling K et al. . Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression. Neoplasia 2015;17:301305.

    • Search Google Scholar
    • Export Citation
  • 161.

    Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004;329:705.

  • 162.

    Rowe DE, Carroll RJ & Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315328.

    • Search Google Scholar
    • Export Citation
  • 163.

    Barlow JO, Zalla MJ, Kyle A et al. . Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 2006;54:10391045.

  • 164.

    Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:11771183.

    • Search Google Scholar
    • Export Citation
  • 165.

    Julian C, Bowers PW, Pritchard C. A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma. Br J Dermatol 2009;161:14071409.

    • Search Google Scholar
    • Export Citation
  • 166.

    Blixt E, Nelsen D, Stratman E. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone. Dermatol Surg 2013;39:719725.

    • Search Google Scholar
    • Export Citation
  • 167.

    Rodriguez-Vigil T, Vazquez-Lopez F, Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol 2007;56:91-95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17190625.

    • Search Google Scholar
    • Export Citation
  • 168.

    Kopf AW, Bart RS, Schrager D et al. . Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977;113:439443.

  • 169.

    Kuijpers DI, Thissen MR, Berretty PJ et al. . Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg 2007;33:579587.

    • Search Google Scholar
    • Export Citation
  • 170.

    Rhodes LE, de Rie MA, Leifsdottir R et al. . Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007;143:11311136.

    • Search Google Scholar
    • Export Citation
  • 171.

    Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340344.

  • 172.

    Rowe DE, Carroll RJ & Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424431.

    • Search Google Scholar
    • Export Citation
  • 173.

    Mosterd K, Krekels GA, Nieman FH et al. . Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008;9:11491156.

    • Search Google Scholar
    • Export Citation
  • 174.

    van Loo E, Mosterd K, Krekels GA et al. . Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer 2014;50:30113020.

    • Search Google Scholar
    • Export Citation
  • 175.

    Mendenhall WM, Amdur RJ, Hinerman RW et al. . Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009;119:19941999.

    • Search Google Scholar
    • Export Citation
  • 176.

    Wilder RB, Kittelson JM, Shimm DS. Basal cell carcinoma treated with radiation therapy. Cancer 1991;68:21342137.

  • 177.

    Wilder RB, Shimm DS, Kittelson JM et al. . Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991;127:16681672.

  • 178.

    Childers BJ, Goldwyn RM, Ramos D et al. . Long-term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg 1994;93:11691173.

    • Search Google Scholar
    • Export Citation
  • 179.

    Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453459.

    • Search Google Scholar
    • Export Citation
  • 180.

    Silverman MK, Kopf AW, Gladstein AH et al. . Recurrence rates of treated basal cell carcinomas: part 4: x-ray therapy. J Dermatol Surg Oncol 1992;18:549554.

    • Search Google Scholar
    • Export Citation
  • 181.

    Zagrodnik B, Kempf W, Seifert B et al. . Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003;98:27082714.

    • Search Google Scholar
    • Export Citation
  • 182.

    Cognetta AB, Howard BM, Heaton HP et al. . Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol 2012;67:12351241.

    • Search Google Scholar
    • Export Citation
  • 183.

    Avril MF, Auperin A, Margulis A et al. . Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76:100106.

    • Search Google Scholar
    • Export Citation
  • 184.

    Petit JY, Avril MF, Margulis A et al. . Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000;105:25442551.

    • Search Google Scholar
    • Export Citation
  • 185.

    Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol 2007;4:462-469.

  • 186.

    Mendenhall WM, Ferlito A, Takes RP et al. . Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol 2012;48:918922.

    • Search Google Scholar
    • Export Citation
  • 187.

    Han A, Ratner D. What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer 2007;109:10531059.

    • Search Google Scholar
    • Export Citation
  • 188.

    Braathen LR, Szeimies RM, Basset-Seguin N et al. . Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007;56:125143.

    • Search Google Scholar
    • Export Citation
  • 189.

    Geisse J, Caro I, Lindholm J et al. . Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004;50:722733.

    • Search Google Scholar
    • Export Citation
  • 190.

    Schulze HJ, Cribier B, Requena L et al. . Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005;152:939947.

    • Search Google Scholar
    • Export Citation
  • 191.

    Quirk C, Gebauer K, De'Ambrosis B et al. . Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis 2010;85:318324.

    • Search Google Scholar
    • Export Citation
  • 192.

    Bath-Hextall F, Ozolins M, Armstrong SJ et al. . Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 2014;15:96105.

    • Search Google Scholar
    • Export Citation
  • 193.

    Arits AH, Mosterd K, Essers BA et al. . Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013;14:647654.

    • Search Google Scholar
    • Export Citation
  • 194.

    Hall VL, Leppard BJ, McGill J et al. . Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986;37:3334.

  • 195.

    Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg 1996;22:854858.

    • Search Google Scholar
    • Export Citation
  • 196.

    Wang I, Bendsoe N, Klinteberg CA et al. . Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001;144:832840.

    • Search Google Scholar
    • Export Citation
  • 197.

    Basset-Seguin N, Ibbotson SH, Emtestam L et al. . Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008;18:547553.

    • Search Google Scholar
    • Export Citation
  • 198.

    Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg 2004;30:297-300.

  • 199.

    Thissen MR, Nieman FH, Ideler AH et al. . Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000;26:759764.

    • Search Google Scholar
    • Export Citation
  • 200.

    Kuijpers DI, Thissen MR, Thissen CA, Neumann MH. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 2006;5:642645.

    • Search Google Scholar
    • Export Citation
  • 201.

    Savoia P, Deboli T, Previgliano A, Broganelli P. Usefulness of photodynamic therapy as a possible therapeutic alternative in the treatment of basal cell carcinoma. Int J Mol Sci 2015;16:2330023317.

    • Search Google Scholar
    • Export Citation
  • 202.

    Berroeta L, Clark C, Dawe RS et al. . A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 2007;157:401403.

    • Search Google Scholar
    • Export Citation
  • 203.

    Szeimies RM, Ibbotson S, Murrell DF et al. . A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008;22:13021311.

    • Search Google Scholar
    • Export Citation
  • 204.

    Roozeboom MH, Aardoom MA, Nelemans PJ et al. . Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. J Am Acad Dermatol 2013;69:280287.

    • Search Google Scholar
    • Export Citation
  • 205.

    Cosgarea R, Susan M, Crisan M, Senila S. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol 2013;27:980984.

    • Search Google Scholar
    • Export Citation
  • 206.

    Wang H, Xu Y, Shi J et al. . Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed 2015;31:4453.

    • Search Google Scholar
    • Export Citation
  • 207.

    Stebbins WG, Hanke CW. MAL-PDT for difficult to treat nonmelanoma skin cancer. Dermatol Ther 2011;24:8293.

  • 208.

    Fantini F, Greco A, Del Giovane C et al. . Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol 2011;25:896901.

    • Search Google Scholar
    • Export Citation
  • 209.

    Horn M, Wolf P, Wulf HC et al. . Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003;149:12421249.

    • Search Google Scholar
    • Export Citation
  • 210.

    Vinciullo C, Elliott T, Francis D et al. . Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult-to-treat’ basal cell carcinoma. Br J Dermatol 2005;152:765772.

    • Search Google Scholar
    • Export Citation
  • 211.

    Sotiriou E, Apalla Z, Maliamani F et al. . Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol 2009;23:10611065.

    • Search Google Scholar
    • Export Citation
  • 212.

    Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008;159:12451266.

  • 213.

    Roozeboom MH, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol 2012;167:733756.

    • Search Google Scholar
    • Export Citation
  • 214.

    Roozeboom MH, Nelemans PJ, Mosterd K et al. . Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. Br J Dermatol 2015;172:739745.

    • Search Google Scholar
    • Export Citation
  • 215.

    Prescribing information: ERIVEDGE (vismodegib) capsule for oral use. 2015. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203388s005s006s007s008lbl.pdf. Accessed April 1, 2016.

    • Search Google Scholar
    • Export Citation
  • 216.

    Prescribing information: ODOMZO (sonidegib) capsules, for oral use. 2015. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205266s000lbl.pdf. Accessed April 1, 2016.

    • Search Google Scholar
    • Export Citation
  • 217.

    Sekulic A, Migden MR, Oro AE et al. . Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012;366:21712179.

  • 218.

    Sekulic A, Migden MR, Lewis K et al. . Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 2015;72:10211026 e1028.

    • Search Google Scholar
    • Export Citation
  • 219.

    Dreno B, Basset-Seguin N, Caro I et al. . Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma. Oncologist 2014;19:790796.

    • Search Google Scholar
    • Export Citation
  • 220.

    Tang JY, Mackay-Wiggan JM, Aszterbaum M et al. . Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012;366:21802188.

    • Search Google Scholar
    • Export Citation
  • 221.

    Chang AL, Solomon JA, Hainsworth JD et al. . Expanded access study of patients with advanced basal cell carcinoma treated with the hedgehog pathway inhibitor, vismodegib. J Am Acad Dermatol 2014;70:6069.

    • Search Google Scholar
    • Export Citation
  • 222.

    Basset-Seguin N, Hauschild A, Grob JJ et al. . Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. Lancet Oncol 2015;16:729736.

    • Search Google Scholar
    • Export Citation
  • 223.

    Migden MR, Guminski A, Gutzmer R et al. . Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol 2015;16:716728.

    • Search Google Scholar
    • Export Citation
  • 224.

    Danial C, Sarin KY, Oro AE, Chang AL. An investigator-initiated open-label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib. Clin Cancer Res 2016;22:13251329.

    • Search Google Scholar
    • Export Citation
  • 225.

    Ally MS, Aasi S, Wysong A et al. . An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. J Am Acad Dermatol 2014;71:904911, e901.

    • Search Google Scholar
    • Export Citation
  • 226.

    Mortier L, Saiag P, Leccia MT et al. . A phase II study to assess vismodegib in the neoadjuvant treatment of locally advanced basal cell carcinoma (laBCC): the Vismodegib Neoadjuvant (VISMONEO) study [abstract]. ASCO Meeting Abstracts 2014;32:TPS9104.

    • Search Google Scholar
    • Export Citation
  • 227.

    Leiter U, Hillen U, Gutzmer R et al. . A phase II, single-armed, multicenter trial of neoadjuvant vismodegib in patients with large and/or recurrent basal cell carcinoma [abstract]: NICCI. ASCO Meeting Abstracts 2014;32:TPS9116.

    • Search Google Scholar
    • Export Citation
  • 228.

    Kunstfeld R, Hauschild A, Zloty D et al. . MIKIE: A randomized, double-blind, regimen-controlled, phase II, multicenter study to assess the efficacy and safety of two different vismodegib regimens in patients with multiple basal cell carcinomas [abstract]. ASCO Meeting Abstracts 2014;32:TPS9121.

    • Search Google Scholar
    • Export Citation
  • 229.

    Sofen H, Gross KG, Goldberg LH et al. . A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma. J Am Acad Dermatol 2015;73:99105, e101.

    • Search Google Scholar
    • Export Citation
  • 230.

    Lacouture ME, Tang JY, Rogers GS et al. . The RegiSONIC disease registry: preliminary effectiveness and safety in the first 66 newly diagnosed locally advanced basal cell carcinoma (BCC) patients treated with vismodegib [abstract]. ASCO Meeting Abstracts 2015;33:9023.

    • Search Google Scholar
    • Export Citation
  • 231.

    Tauber G, Pavlovsky L, Fenig E, Hodak E. Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp. J Am Acad Dermatol 2015;73:799801.

    • Search Google Scholar
    • Export Citation
  • 232.

    Jimeno A, Weiss GJ, Miller WH Jr. et al. . Phase I study of the hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. Clin Cancer Res 2013;19:27662774.

    • Search Google Scholar
    • Export Citation
  • 233.

    Kim DJ, Kim J, Spaunhurst K et al. . Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. J Clin Oncol 2014;32:745751.

    • Search Google Scholar
    • Export Citation
  • 234.

    Carneiro BA, Watkin WG, Mehta UK, Brockstein BE. Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest 2006;24:396400.

    • Search Google Scholar
    • Export Citation
  • 235.

    Jefford M, Kiffer JD, Somers G et al. . Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg 2004;74:704705.

    • Search Google Scholar
    • Export Citation
  • 236.

    Ganti AK, Kessinger A. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev 2011;37:440443.

    • Search Google Scholar
    • Export Citation
  • 237.

    Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol 2013;149:615616.

    • Search Google Scholar
    • Export Citation
  • 238.

    Pfeiffer P, Hansen O, Rose C. Systemic cytotoxic therapy of basal cell carcinoma: a review of the literature. Eur J Cancer 1990;26:7377.

  • 239.

    Moeholt K, Aagaard H, Pfeiffer P, Hansen O. Platinum-based cytotoxic therapy in basal cell carcinoma: a review of the literature. Acta Oncol 1996;35:677682.

    • Search Google Scholar
    • Export Citation
  • 240.

    Guthrie TH Jr., Porubsky ES, Luxenberg MN et al. . Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 1990;8:342346.

    • Search Google Scholar
    • Export Citation
  • 241.

    Robinson JK. Follow-up and prevention (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Science; 1998:695698.

    • Search Google Scholar
    • Export Citation
  • 242.

    Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000;136:15241530.

    • Search Google Scholar
    • Export Citation
  • 243.

    Ramachandran S, Rajaratnam R, Smith AG et al. . Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma. J Am Acad Dermatol 2009;61:247251.

    • Search Google Scholar
    • Export Citation
  • 244.

    Flohil SC, van der Leest RJ, Arends LR et al. . Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 2013;49:23652375.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 5988 2778 294
PDF Downloads 2359 1407 257
EPUB Downloads 0 0 0